Cold War tensions and the polio vaccine Sabin vaccine from the Soviet side. However other Soviet virologists argued that the Salk vaccine could be considered safe, since the Americans tested it on their own people. They considered that the Sabin vaccine must be potentially dangerous because the Americans did not wish to test it on their own society. The documented achievement of the Sabin-Chumakov collaboration eventually trumped the ideological differences of the Cold War. Their oral live-virus vaccine became federally licensed in 1962, and used for over three decades to help eliminate polio globally, replacing the Salk vaccine. Using these vaccines, the threat of polio remains only
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS